347 related articles for article (PubMed ID: 15217651)
21. Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
Uematsu T; Kasami M; Yuen S
Breast Cancer; 2009; 16(2):97-104. PubMed ID: 18663562
[TBL] [Abstract][Full Text] [Related]
22. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
AJR Am J Roentgenol; 2003 Apr; 180(4):901-10. PubMed ID: 12646427
[TBL] [Abstract][Full Text] [Related]
23. Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging.
Hulvat M; Sandalow N; Rademaker A; Helenowski I; Hansen NM
Surgery; 2010 Oct; 148(4):746-50; discussion 750-1. PubMed ID: 20708761
[TBL] [Abstract][Full Text] [Related]
24. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
25. Is there a role for MRI in the preoperative assessment of patients with DCIS?
Allen LR; Lago-Toro CE; Hughes JH; Careaga E; Brown AT; Chernick M; Barrio AV; Frazier TG
Ann Surg Oncol; 2010 Sep; 17(9):2395-400. PubMed ID: 20217259
[TBL] [Abstract][Full Text] [Related]
26. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.
Baltzer PA; Dietzel M; Vag T; Burmeister H; Gajda M; Camara O; Pfleiderer SO; Kaiser WA
Rofo; 2011 May; 183(5):441-7. PubMed ID: 21318935
[TBL] [Abstract][Full Text] [Related]
27. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
28. The effect of margins on the clinical management of ductal carcinoma in situ of the breast.
Meijnen P; Gilhuijs KG; Rutgers EJ
J Surg Oncol; 2008 Dec; 98(8):579-84. PubMed ID: 19072848
[TBL] [Abstract][Full Text] [Related]
29. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ.
Solin LJ; Orel SG; Hwang WT; Harris EE; Schnall MD
J Clin Oncol; 2008 Jan; 26(3):386-91. PubMed ID: 18202414
[TBL] [Abstract][Full Text] [Related]
30. Does Initial Imaging Modality Affect Breast Biopsy Upgrade Rates? A Single Institution Review.
Scott RB; Dolkar T; Vidhun R; Osler T; Staradub VL
Conn Med; 2016; 80(6):335-40. PubMed ID: 27509639
[TBL] [Abstract][Full Text] [Related]
31. Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study.
Brogi E; Robson M; Panageas KS; Casadio C; Ljung BM; Montgomery L
Cancer; 2003 Nov; 98(10):2170-6. PubMed ID: 14601086
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the Diagnostic Accuracy of Magnetic Resonance Imaging with Sonography in the Prediction of Breast Cancer Tumor Size: A Concordance Analysis with Histopathologically Determined Tumor Size.
Lai HW; Chen DR; Wu YC; Chen CJ; Lee CW; Kuo SJ; Chen ST; Wu HK
Ann Surg Oncol; 2015 Nov; 22(12):3816-23. PubMed ID: 25707494
[TBL] [Abstract][Full Text] [Related]
33. Classification system for identifying women at risk for altered partial breast irradiation recommendations after breast magnetic resonance imaging.
Kowalchik KV; Vallow LA; McDonough M; Thomas CS; Heckman MG; Peterson JL; Adkisson CD; Serago C; McLaughlin SA
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):127-33. PubMed ID: 23920391
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer: non-metastatic.
Dixon JM; Gregory K; Johnston S; Rodger A
Clin Evid; 2002 Dec; (8):1811-39. PubMed ID: 12603971
[No Abstract] [Full Text] [Related]
35. Does Preoperative MRI Workup Affect Mastectomy Rates and/or Re-excision Rates in Patients with Newly Diagnosed Breast Carcinoma? A Retrospective Review.
Patel BK; Shah NA; Galgano SJ; Newell M; Wang Z; Chen Z; D'Orsi CJ
Breast J; 2015; 21(6):604-9. PubMed ID: 26387498
[TBL] [Abstract][Full Text] [Related]
36. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
[No Abstract] [Full Text] [Related]
37. Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens.
Behjatnia B; Sim J; Bassett LW; Moatamed NA; Apple SK
Int J Clin Exp Pathol; 2010 Feb; 3(3):303-9. PubMed ID: 20224728
[TBL] [Abstract][Full Text] [Related]
38. [Hydronephrosis as the first manifestation of primary metastatic breast cancer].
Kuhn W; Loos W; Graeff H
Geburtshilfe Frauenheilkd; 1994 May; 54(5):308-10. PubMed ID: 8050693
[TBL] [Abstract][Full Text] [Related]
39. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.
Brachtel EF; Rusby JE; Michaelson JS; Chen LL; Muzikansky A; Smith BL; Koerner FC
J Clin Oncol; 2009 Oct; 27(30):4948-54. PubMed ID: 19720921
[TBL] [Abstract][Full Text] [Related]
40. [A practice guideline for diagnosis and treatment of ductal in situ carcinoma of the breast].
Delaloye JF; Wight E; Fink D; Otto R; Steiner R;
Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):64-7. PubMed ID: 16452823
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
